Sun Pharmaceutical Industries rallied 6.50% to Rs 377.90 after the company said its board will consider share buyback on Tuesday, 17 March 2020.
The announcement was made after market hours yesterday, 12 March 2020. The stock hit a 52-week low at Rs 336.55 in early trade today.Shares of Sun Pharmaceutical Industries dropped 12.53% in the past five trading sessions to settle at Rs 354.85 yesterday, 12 March 2020 from its close of Rs 405.70 on 4 March 2020.
Sun Pharmaceutical Industries' consolidated net profit tanked 26.4% to Rs 913.52 crore on a 5% increase in net sales to Rs 8,038.65 crore in Q3 December 2019 over Q3 December 2018.
Sun Pharmaceutical Industries' business segments include US Business, Indian branded generics business, Emerging markets, Global consumer healthcare business and Active Pharmaceutical Ingredients (API).
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app